Richard Scott Struthers - President & CEO, Director at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
CRNX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Richard Scott Struthers - trading volume in the past year for Crinetics Pharmaceuticals, Inc.

Holdings reported by Richard Scott Struthers for Crinetics Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 571K $32.9M $57.57 Dec 2, 2024 By Family Trust 1
Common Stock 257K $14.8M $57.57 Dec 2, 2024 Direct
Common Stock 110K $6.33M $57.57 Dec 2, 2024 By Family Trust 2
Common Stock 110K $6.33M $57.57 Dec 2, 2024 By Family Trust 3
Common Stock 100K $5.76M $57.57 Dec 2, 2024 By Family Trust 4
Common Stock 1K $57.6K $57.57 Dec 2, 2024 By Spouse
Stock Option (Right to Buy) 16.3K May 8, 2024 Direct Common Stock

Transactions reported by Richard Scott Struthers for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.